The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 21.25
Bid: 20.50
Ask: 22.00
Change: 0.15 (0.71%)
Spread: 1.50 (7.317%)
Open: 21.50
High: 22.00
Low: 21.25
Prev. Close: 21.10
IOF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Management changes

8 Mar 2010 07:00

RNS Number : 2049I
Iofina PLC
08 March 2010
 



 

8 March 2010

Iofina plc

 ("Iofina" or "the Company" or "the Group")

 

MANAGEMENT CHANGE

 

 

The Board of Iofina announces that following an organisation review in the light of the broadening scope of the Company's business Lance Baller, currently Finance Director of the Group, has been appointed as CEO of the Group in place of David Schneider, with immediate effect. It is expected that a new appointment to the role of Finance Director will be made shortly.

 Also, effective immediately, Dr Tom Becker has been appointed as President of Iofina Chemical Inc.

Dr. Becker was the former vice president of Research and Development at H&S/Iofina Chemical. Iofina bought H&S Chemical in July 2009 for complete vertical integration into the iodine chemical derivatives market. Dr. Becker has conducted extensive research in both inorganic and organic halogen based chemistry. Dr. Becker has written a magnitude of published technical papers in his career. Prior to H&S Dr. Becker worked as an Oak Ridge Scholar on behalf of the US EPA and worked for various other chemical manufacturing companies. Dr. Becker earned a BS in Chemistry from Indiana University, and a PhD in Chemistry from the University of Cincinnati. He has extensive experience in scale-up of chemical processes from laboratory to pilot to full scale production and is the inventor on several chemical patents/patent applications.

Dr. Chris Fay CBE, Non Executive Chairman commented:

"We are continually looking to strengthen Iofina's management team and Board as evidenced by a number of personnel announcements. As the Company's focus now transitions from one of exploration and technology development towards production, contract negotiations and cash generation, the Board has concluded that Lance is best placed to lead the Company through this next phase of growth to drive shareholder value creation."

For further information, please contact:

Chris Fay, Non-Exec Chairman

Iofina plc

Tel: +44(0)20 3006 3135

 

Nominated Adviser:

James Harris/Angela Peace

Strand Hanson Limited

Tel: +44(0)20 7409 3494

 

Broker:

Rory Scott

Mirabaud Securities Limited

Tel: +44(0)20 7878 3360

 

Media Contact:

Klara Kaczmarek

Pelham Bell Pottinger

Tel: +44 (0)20 7337 1524

About Iofina

Iofina is involved in the exploration and production of both iodine and natural gas with complete vertical integration into the specialty chemical iodine derivatives business. It also provides third party brine stream operators with a turnkey solution to extract iodine. The presence of both iodine and natural gas has been discovered on acreages which the Company holds through its wholly owned subsidiary Iofina Natural Gas, Inc. The presence of both iodine and natural gas allows the Group to generate dual revenue streams over a single cost structure.

Iofina is traded on the London Stock Exchange's AIM Market under the ticker: IOF

www.Iofina.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUGUMCWUPUPUM
Date   Source Headline
22nd Sep 20207:00 amRNSDebt Refinancing Signed
26th Aug 20207:00 amRNSDebt Update
31st Jul 20208:00 amRNSLaunch of new website
22nd Jul 202011:06 amRNSSecond Price Monitoring Extn
22nd Jul 202011:00 amRNSPrice Monitoring Extension
22nd Jul 20207:00 amRNSCorporate Update
30th Jun 20202:36 pmRNSDebt Update
30th Jun 202011:52 amRNSResult of AGM
26th Jun 20201:26 pmRNSChange of venue for AGM on 30 June 2020
26th Jun 20207:00 amRNSIO#8 and Debt Update
27th May 20207:00 amRNSFinal Results
19th May 20204:41 pmRNSSecond Price Monitoring Extn
19th May 20204:36 pmRNSPrice Monitoring Extension
15th May 20204:40 pmRNSSecond Price Monitoring Extn
15th May 20204:35 pmRNSPrice Monitoring Extension
14th May 20207:00 amRNSPPP Loan Received
4th May 20207:00 amRNSIO#8 Brine Supply Update
14th Apr 20207:00 amRNSQ1 Market Update
2nd Apr 20207:00 amRNSDirectorate Change
26th Mar 20201:53 pmRNSWithdrawal of requisition for General Meeting
19th Mar 202012:08 pmRNSSecond Price Monitoring Extn
19th Mar 202012:03 pmRNSPrice Monitoring Extension
17th Mar 20204:41 pmRNSSecond Price Monitoring Extn
17th Mar 20204:35 pmRNSPrice Monitoring Extension
16th Mar 202012:07 pmRNSSecond Price Monitoring Extn
16th Mar 202012:02 pmRNSPrice Monitoring Extension
12th Mar 20204:41 pmRNSSecond Price Monitoring Extn
12th Mar 20204:36 pmRNSPrice Monitoring Extension
12th Mar 20201:56 pmRNSClarification Regarding Media Reports
11th Mar 202012:08 pmRNSSecond Price Monitoring Extn
11th Mar 202012:02 pmRNSPrice Monitoring Extension
10th Mar 20207:30 amRNSBoard response to recent GM request
10th Mar 20207:00 amRNSRequisition of General Meeting
3rd Mar 20207:10 amRNSStatement re: press and social media reports
2nd Mar 202012:22 pmRNSHolding(s) in Company
25th Feb 202012:00 pmRNSMarket Update
10th Feb 20205:15 pmRNSHolding(s) in Company
10th Feb 20205:15 pmRNSHolding(s) in Company
16th Jan 20207:00 amRNSMarket Update - Strong H2 2019
2nd Jan 202011:11 amRNSHolding(s) in Company
20th Dec 20197:00 amRNSTrading Update
14th Nov 20193:51 pmRNSHolding(s) in Company
14th Nov 20193:50 pmRNSHolding(s) in Company
12th Nov 20191:43 pmRNSHolding(s) in Company
6th Nov 20197:00 amRNSIofinaEX Hemp Seed Investment
14th Oct 20197:00 amRNSQ3 2019 Update
26th Sep 201910:00 amRNSHolding(s) in Company
25th Sep 20194:35 pmRNSPrice Monitoring Extension
23rd Sep 20197:00 amRNSInterim Results
18th Sep 20197:00 amRNSTerms for IO#8 Finalised - Construction Commences

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.